Daud, Shaira I.
HRN: 28-21-73 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2025
CEFTRIAXONE 1G (VIAL)
12/05/2025
12/12/2025
IV DRIP
1.9g
Q24hours
PCAP-B; T/c Obstructive Jaundice
Checking Initial Appropriateness
12/05/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
12/05/2025
12/08/2025
PO
5ml
BID
Intestinal Parasitism
Checking Initial Appropriateness
12/06/2025
CEFUROXIME 750MG (VIAL)
12/06/2025
12/13/2025
IV
630mg
Q8hours
PCAP-B
Checking Final Appropriateness
12/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/06/2025
12/13/2025
IV
190mg
Q8
Hepa A
Checking Initial Appropriateness